A citation-based method for searching scientific literature

Yiqiu Yao, Astrid-Helene Ravn Jørgensen, Simon Francis Thomsen. J Dermatolog Treat 2020
Times Cited: 9







List of co-cited articles
3 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Therapeutic pipeline for atopic dermatitis: End of the drought?
Amy S Paller, Kenji Kabashima, Thomas Bieber. J Allergy Clin Immunol 2017
131
22

Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations.
Paolo Gisondi, Marina Talamonti, Andrea Chiricozzi, Stefano Piaserico, Paolo Amerio, Anna Balato, Federico Bardazzi, Piergiacomo Calzavara Pinton, Anna Campanati, Angelo Cattaneo,[...]. Dermatol Ther (Heidelb) 2021
12
22

New generation biologics for the treatment of psoriasis and psoriatic arthritis. State of the art and considerations about the risk of infection.
Manuela Ceccarelli, Emmanuele Venanzi Rullo, Massimiliano Berretta, Bruno Cacopardo, Giovanni Francesco Pellicanò, Giuseppe Nunnari, Claudio Guarneri. Dermatol Ther 2021
5
40

1
100

New biologics in the treatment of urticaria.
Emek Kocatürk, Torsten Zuberbier. Curr Opin Allergy Clin Immunol 2018
14
11

Old and New Biological Therapies for Psoriasis.
Kirsten Rønholt, Lars Iversen. Int J Mol Sci 2017
114
11


Successful response in a case of severe pustular psoriasis after interleukin-1β inhibition.
P Skendros, C Papagoras, I Lefaki, A Giatromanolaki, I Kotsianidis, M Speletas, V Bocly, I Theodorou, V Dalla, K Ritis. Br J Dermatol 2017
49
11


Future therapies for pemphigus vulgaris: Rituximab and beyond.
Amy Huang, Raman K Madan, Jacob Levitt. J Am Acad Dermatol 2016
26
11

Immunomodulating Agents as Antipruritics.
Stephen Erickson, Zachary Nahmias, Ilana S Rosman, Brian S Kim. Dermatol Clin 2018
13
11


Pharmacokinetic characteristics of therapeutic antibodies.
Johannes Wohlrab. J Dtsch Dermatol Ges 2015
13
11

Trifunctional antibodies unleash NK cells.
Alexandra Flemming. Nat Rev Cancer 2019
3
33


MicroRNAs in cancer: biomarkers, functions and therapy.
Josie Hayes, Pier Paolo Peruzzi, Sean Lawler. Trends Mol Med 2014
11

Modelling of the Time-Varying Pharmacokinetics of Therapeutic Monoclonal Antibodies: A Literature Review.
Antoine Petitcollin, Amina Bensalem, Marie-Clémence Verdier, Camille Tron, Florian Lemaitre, Gilles Paintaud, Eric Bellissant, David Ternant. Clin Pharmacokinet 2020
11
11

Pharmacokinetics of Monoclonal Antibodies.
Josiah T Ryman, Bernd Meibohm. CPT Pharmacometrics Syst Pharmacol 2017
309
11


Cloning single-chain antibody fragments (ScFv) from hyrbidoma cells.
Lars Toleikis, André Frenzel. Methods Mol Biol 2012
12
11

Side effects of the biologics.
Warren R Heymann. J Am Acad Dermatol 2005
4
25


Design and Production of Bispecific Antibodies.
Qiong Wang, Yiqun Chen, Jaeyoung Park, Xiao Liu, Yifeng Hu, Tiexin Wang, Kevin McFarland, Michael J Betenbaugh. Antibodies (Basel) 2019
65
11




Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation.
Jacob O'Brien, Heyam Hayder, Yara Zayed, Chun Peng. Front Endocrinol (Lausanne) 2018
11


Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview.
Pieter Hindryckx, Gregor Novak, Niels Vande Casteele, Reena Khanna, Debby Laukens, Vipul Jairath, Brian G Feagan. Drugs 2017
29
11

Bispecific antibodies in cancer immunotherapy.
Eva Dahlén, Niina Veitonmäki, Per Norlén. Ther Adv Vaccines Immunother 2018
99
11


Integrated Pharmacokinetic/Pharmacodynamic Analysis for Determining the Minimal Anticipated Biological Effect Level of a Novel Anti-CD28 Receptor Antagonist BMS-931699.
Zheng Yang, Haiqing Wang, Theodora W Salcedo, Suzanne J Suchard, Jenny H Xie, Lumelle A Schneeweis, Catherine A Fleener, James D Calore, Rong Shi, Sean X Y Zhang,[...]. J Pharmacol Exp Ther 2015
11
11

Systematic review of anti-drug antibodies of IL-17 inhibitors for psoriasis.
Logan W Thomas, Erica B Lee, Jashin J Wu. J Dermatolog Treat 2019
20
11



Antibody-Drug Conjugates: Pharmacokinetic/Pharmacodynamic Modeling, Preclinical Characterization, Clinical Studies, and Lessons Learned.
William D Hedrich, Tamer E Fandy, Hossam M Ashour, Hongbing Wang, Hazem E Hassan. Clin Pharmacokinet 2018
38
11



Trifunctional metasurfaces: concept and characterizations.
Weikang Pan, Tong Cai, Shiwei Tang, Lei Zhou, Jianfeng Dong. Opt Express 2018
7
14


Immunogenicity of Innovative and Biosimilar Monoclonal Antibodies.
Erik Doevendans, Huub Schellekens. Antibodies (Basel) 2019
38
11



How chemokines invite leukocytes to dance.
Marcus Thelen, Jens V Stein. Nat Immunol 2008
228
11

Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study.
Craig Leonardi, Catherine Maari, Sandra Philipp, Orin Goldblum, Lu Zhang, Nicole Burkhardt, Susan Ball, Lotus Mallbris, Pablo Gonzalez, Pablo Fernández-Peñas,[...]. J Am Acad Dermatol 2018
34
11

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis.
Kenneth B Gordon, Andrew Blauvelt, Kim A Papp, Richard G Langley, Thomas Luger, Mamitaro Ohtsuki, Kristian Reich, David Amato, Susan G Ball, Daniel K Braun,[...]. N Engl J Med 2016
460
11

Psoriasis pathogenesis and the development of novel targeted immune therapies.
Jason E Hawkes, Tom C Chan, James G Krueger. J Allergy Clin Immunol 2017
374
11


Psoriasis as a model for T-cell-mediated disease: immunobiologic and clinical effects of treatment with multiple doses of efalizumab, an anti-CD11a antibody.
Alice B Gottlieb, James G Krueger, Knut Wittkowski, Russell Dedrick, Patricia Ann Walicke, Marvin Garovoy. Arch Dermatol 2002
176
11

Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity.
Mikako Ogawa, Yusuke Tomita, Yuko Nakamura, Min-Jung Lee, Sunmin Lee, Saori Tomita, Tadanobu Nagaya, Kazuhide Sato, Toyohiko Yamauchi, Hidenao Iwai,[...]. Oncotarget 2017
107
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.